Yukio Hiroi
Overview
Explore the profile of Yukio Hiroi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
78
Citations
927
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lu J, Kubo S, Hashimoto M, Hayashi Y, Masuda E, Sadatsuki M, et al.
Glob Health Med
. 2025 Mar;
7(1):74-76.
PMID: 40026849
In the post-COVID-19 era, inbound medical care in Japan adapted to the growing demand for high-quality and precise healthcare. One form of this care is a complete medical examination, which...
2.
Tomidokoro D, Nakamura T, Oka S, Miyazaki Y, Wakamiya A, Ueda N, et al.
Circ Genom Precis Med
. 2024 Oct;
17(6):e004671.
PMID: 39469765
No abstract available.
3.
Fukuma N, Tokiwa H, Numata G, Ueda K, Liu P, Tajima M, et al.
Cardiovasc Res
. 2024 Sep;
120(15):1884-1897.
PMID: 39259833
Aims: Oestrogen exerts beneficial cardiovascular effects by binding to specific receptors on various cells to activate nuclear and non-nuclear actions. Oestrogen receptor α (ERα) non-nuclear signalling confers protection against heart...
4.
Yamamoto J, Hayama H, Enomoto Y, Yamamoto M, Hara H, Hiroi Y
J Arrhythm
. 2024 Jun;
40(3):489-500.
PMID: 38939759
Background: Patients with atrial fibrillation (AF) and heart failure (HF) have high stroke risk owing to left atrial dysfunction. However, anticoagulation is a concern in patients with high bleeding risk....
5.
Nagao A, Chikasawa Y, Hiroi Y, Ieko M
Haemophilia
. 2024 May;
30(4):933-942.
PMID: 38783547
Introduction: Cardiovascular diseases (CVD) that require long-term anticoagulant and antiplatelet therapy presents a problem in people with haemophilia (PWH) who receive factor replacement therapy to reduce bleeding risk. Currently, there...
6.
Kusumoto M, Yamamoto J, Kaneda S, Matsushiro T, Yamamoto M, Hara H, et al.
Int Heart J
. 2024 May;
65(3):572-579.
PMID: 38749747
A 55-year-old man presented to the emergency department with worsening shortness of breath 1 month after a gastrointestinal bleed. He had congestive heart failure, and an electrocardiogram suggested ischemic heart...
7.
Yamamoto M, Hara H, Kubota S, Hiroi Y
EuroIntervention
. 2024 May;
20(9):602-612.
PMID: 38726721
Background: Late lumen enlargement (LLE) - a positive remodelling phenomenon - after drug-coated balloon (DCB) angioplasty for stable coronary disease contributes to a lower restenosis rate. However, lesion characteristics promoting...
8.
Nagai R, Ogata M, Kubota S, Yamamoto M, Uemura H, Tanuma J, et al.
Glob Health Med
. 2024 May;
6(2):124-131.
PMID: 38690129
An extremely high prevalence (12.2%) of moderate-to-severe coronary artery stenosis (CAS) was documented in asymptomatic Japanese haemophiliacs living with HIV-1 (JHLH) in our previous study. The cause of this phenomenon...
9.
Kurozumi A, Enomoto Y, Hara H, Kato N, Hiroi Y
Int Heart J
. 2024 Mar;
65(2):354-358.
PMID: 38556343
Although long-QT syndrome (LQTS) with a normal range QT interval at rest leads to fatal ventricular arrhythmias, it is difficult to diagnose. In this article, we present a rare case...
10.
Yoshihara F, Imazu M, Sakuma I, Hiroi Y, Hara H, Okazaki O, et al.
EClinicalMedicine
. 2024 Jan;
66:102334.
PMID: 38192595
Background: Sodium-glucose cotransporter 2 (SGLT2) inhibitors reduce the urinary albumin-to-creatinine ratio (UACR) in patients with elevated levels of albuminuria in the presence or absence of heart failure (HF) or type...